ClinicalTrials.Veeva

Menu

Japanese CTO PCI Expert Registry

K

Kurashiki Central Hospital

Status

Enrolling

Conditions

Chronic Total Occlusion of Coronary Artery

Study type

Observational

Funder types

Other

Identifiers

NCT01889459
J-CTOPCI-ER2013

Details and patient eligibility

About

The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.

Enrollment

19,000 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients eligible for PCI

Patients who underwent PCI for CTO lesions that contain the following:

  1. Thrombolysis in myocardial infarction trial (TIMI) 0
  2. The occlusive period more than 3 months or unknown
  3. The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft

Exclusion criteria

Patients ineligible for PCI judged in clinical practice

Trial design

19,000 participants in 1 patient group

PCI for CTO

Trial contacts and locations

1

Loading...

Central trial contact

Harumi Katoh, MD, PhD; Keiko Oka

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems